Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Hypersensitivity Reaction

  Free Subscription


14.11.2022

1 Acta Derm Venereol
12 Allergy Asthma Proc
11 Ann Allergy Asthma Immunol
1 BMC Pediatr
1 Chest
1 Dermatology
5 Eur Respir J
4 Int Arch Allergy Immunol
11 J Allergy Clin Immunol
2 J Immunol
1 Pediatr Dermatol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Derm Venereol

  1. TIZEK L, Wecker H, Schneider S, Johansson EK, et al
    Eczema-related Web Search Data in Sweden: Investigating Search Patterns and the Influence of Weather.
    Acta Derm Venereol. 2022;102:adv00810.
    PubMed         Abstract available


    Allergy Asthma Proc

  2. SALAZAR PE, Habib N, Pasha MA
    2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis.
    Allergy Asthma Proc. 2022;43:529-532.
    PubMed         Abstract available

  3. GULTUNA S
    Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes.
    Allergy Asthma Proc. 2022;43:e65-e71.
    PubMed         Abstract available

  4. ALVES PB, Pereira HP, Alves MP, Roseta L, et al
    Predictors of anaphylaxis to peanut and tree nuts in a Mediterranean population.
    Allergy Asthma Proc. 2022;43:533-542.
    PubMed         Abstract available

  5. BELLANTI JA, Settipane RA
    A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors.
    Allergy Asthma Proc. 2022;43:471-473.
    PubMed        

  6. GRISCTI SOLER D, Bennici A, Brunetto S, Gangemi S, et al
    Benralizumab in the management of rare primary eosinophilic lung diseases.
    Allergy Asthma Proc. 2022;43:494-500.
    PubMed         Abstract available

  7. GROSS LM, Nelson HS, Khatiwada A, Hoyte FCL, et al
    Curcumin does not significantly affect immediate skin tests.
    Allergy Asthma Proc. 2022;43:543-545.
    PubMed         Abstract available

  8. OZTOP N, Demir S, Unal D, Beyaz S, et al
    Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study.
    Allergy Asthma Proc. 2022;43:519-528.
    PubMed         Abstract available

  9. WALLACE DV
    Treatment options for moderate to severe atopic dermatitis.
    Allergy Asthma Proc. 2022;43:474-493.
    PubMed         Abstract available

  10. FRENKEL LD, Bellanti JA
    Monkeypox viral infection and disease: A challenge for the allergist-immunologist.
    Allergy Asthma Proc. 2022;43:509-518.
    PubMed         Abstract available

  11. NELSON HS
    The return of the mixed respiratory bacterial vaccine.
    Allergy Asthma Proc. 2022;43:501-508.
    PubMed         Abstract available

  12. OZTOP N, Demir S, Toprak ID, Unal D, et al
    Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course.
    Allergy Asthma Proc. 2022;43:546-554.
    PubMed         Abstract available


  13. Abstracts presented at the Eastern Allergy Conference, June 2-5, 2022, Palm Beach, Florida.
    Allergy Asthma Proc. 2022;43:560-567.
    PubMed        


    Ann Allergy Asthma Immunol

  14. BIGGS SE, Ownby DR, May KR
    Use of over-the-counter inhaled epinephrine in asthma.
    Ann Allergy Asthma Immunol. 2022 Aug 27. pii: S1081-1206(22)01674.
    PubMed        

  15. CHOW TG, Palka JM, Stone B, Trojan T, et al
    Safety of Subcutaneous Immunotherapy in Patients with Severe Asthma.
    Ann Allergy Asthma Immunol. 2022 Aug 20. pii: S1081-1206(22)00693.
    PubMed         Abstract available

  16. JALIL M, Hostoffer Z, Callahan M, Hostoffer R, et al
    Delayed diagnosis of hereditary angioedema in the setting of Prader-Willi syndrome.
    Ann Allergy Asthma Immunol. 2022;129:643-644.
    PubMed        

  17. GOSWAMY VP, Lee KE, McKernan EM, Fichtinger PS, et al
    Omalizumab for treatment of idiopathic angioedema.
    Ann Allergy Asthma Immunol. 2022;129:605-611.
    PubMed         Abstract available

  18. GHIASI Y, Wangberg H, Bagsic SRS, White A, et al
    Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2022;129:642-643.
    PubMed        

  19. GREINER B, Hartwell M
    Prevalence and associations between metabolically unhealthy obesity and asthma exacerbations and emergency department usage.
    Ann Allergy Asthma Immunol. 2022 Jul 14. pii: S1081-1206(22)00590.
    PubMed         Abstract available

  20. ADAM LIEBERMAN J, Borish L
    Update in primary immune deficiencies for the practicing allergist/clinical immunologist.
    Ann Allergy Asthma Immunol. 2022;129:537-538.
    PubMed        

  21. LIEBERMAN JA
    Swelling without hives and normal complement: A new hero?
    Ann Allergy Asthma Immunol. 2022;129:539.
    PubMed        

  22. GREENBERGER PA
    Identifying and classifying patients with hypersensitivity pneumonitis as fibrotic or nonfibrotic instead of as acute, subacute, or chronic.
    Ann Allergy Asthma Immunol. 2022;129:544-545.
    PubMed        

  23. PATEL P, Komorowski AS, Mack DP
    An allergist's approach to food poisoning.
    Ann Allergy Asthma Immunol. 2022 Nov 2. pii: S1081-1206(22)01903.
    PubMed         Abstract available

  24. LEE EY, Jakubovic BD
    IL-6 and Cytokine Release Syndrome: a new understanding in drug hypersensitivity reactions.
    Ann Allergy Asthma Immunol. 2022 Nov 4. pii: S1081-1206(22)01905.
    PubMed         Abstract available


    BMC Pediatr

  25. ZHAO X, Xu Z, Su H, Zheng R, et al
    Two cases of infantile-onset primary generalized glucocorticoid hypersensitivity and the effect of mifepristone.
    BMC Pediatr. 2022;22:650.
    PubMed         Abstract available


    Chest

  26. SMITH KS, Lee SA, Albers BK, Stevens EL, et al
    A 13-Year-Old Male Patient With Severe Multifocal Pneumonia and Bronchiectasis That Required Extracorporeal Membrane Oxygenation.
    Chest. 2022;162:e265-e271.
    PubMed         Abstract available


    Dermatology

  27. SLODOWNIK D, Levi A, Lapidoth M, Moshe S, et al
    Occupational Chronic Contact Dermatitis Successfully Treated with Dupilumab: A Case Series.
    Dermatology. 2022;238:1073-1075.
    PubMed         Abstract available


    Eur Respir J

  28. BUSSE WW
    Improving systemic corticosteroid stewardship in asthma.
    Eur Respir J. 2022;60.
    PubMed        

  29. PARK JS, Cho YJ, Yun JY, Lee HJ, et al
    Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series.
    Eur Respir J. 2022;60.
    PubMed         Abstract available

  30. HABENER A, Grychtol R, Gaedcke S, DeLuca D, et al
    IgA(+) memory B cells are significantly increased in patients with asthma and small airways dysfunction.
    Eur Respir J. 2022 May 20. pii: 13993003.02130-2021.
    PubMed         Abstract available

  31. KROES JA, Zielhuis SW, De Jong K, Hashimoto S, et al
    Cumulative Corticosteroid Sparing Effect of Anti-Interleukin-5/5Ra In Eosinophilic Asthma.
    Eur Respir J. 2022 May 20. pii: 13993003.02983-2021.
    PubMed         Abstract available

  32. THOMAS D, McDonald VM, Pavord ID, Gibson PG, et al
    Asthma remission- what is it and how can it be achieved?
    Eur Respir J. 2022 Mar 31. pii: 13993003.02583-2021.
    PubMed         Abstract available


    Int Arch Allergy Immunol

  33. LAHA A, Moitra S, Biswas H, Saha NC, et al
    Assessment of Co-Sensitization between Pollen and Food Allergen Sources among Bengali Population, West Bengal, India.
    Int Arch Allergy Immunol. 2022 Nov 7:1-10. doi: 10.1159/000526707.
    PubMed         Abstract available

  34. DU L, Xu C, Shi J, Tang L, et al
    Elevated CXCL14 in Induced Sputum Was Associated with Eosinophilic Inflammation and Airway Obstruction in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Sep 5:1-10. doi: 10.1159/000526367.
    PubMed         Abstract available

  35. HASAL E, Bulbul Baskan E, Yazici S, Aydogan K, et al
    Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria.
    Int Arch Allergy Immunol. 2022;183:1198-1208.
    PubMed         Abstract available

  36. CAKMAK ME
    Comparison of the Patients with Chronic Urticaria Who Responded and Did Not Respond to Omalizumab Treatment: A Single-Center Retrospective Study.
    Int Arch Allergy Immunol. 2022;183:1209-1215.
    PubMed         Abstract available


    J Allergy Clin Immunol

  37. NAMJOU B, Lape M, Malolepsza E, DeVore SB, et al
    Multiancestral polygenic risk score for pediatric asthma.
    J Allergy Clin Immunol. 2022 May 17. pii: S0091-6749(22)00660.
    PubMed         Abstract available

  38. VERNET R, Matran R, Zerimech F, Madore AM, et al
    Identification of novel genes influencing eosinophil-specific protein levels in asthma families.
    J Allergy Clin Immunol. 2022 Jun 4. pii: S0091-6749(22)00762.
    PubMed         Abstract available

  39. TURNER PJ, Patel N, Campbell DE, Sampson HA, et al
    Reproducibility of food challenge to cow's milk: Systematic review with individual participant data meta-analysis.
    J Allergy Clin Immunol. 2022;150:1135-1143.
    PubMed         Abstract available

  40. KULIS MD, Smeekens JM, Burk C, Yue X, et al
    Kinetics of basophil hyporesponsiveness during short-course peanut oral immunotherapy.
    J Allergy Clin Immunol. 2022;150:1144-1153.
    PubMed         Abstract available

  41. IRIZAR H, Chun Y, Arditi Z, Do A, et al
    Examination of host genetic effects on nasal microbiome composition.
    J Allergy Clin Immunol. 2022;150:1232-1236.
    PubMed         Abstract available

  42. SAKASHITA M, Takabayashi T, Imoto Y, Homma T, et al
    Retinoic acid promotes fibrinolysis and may regulate polyp formation.
    J Allergy Clin Immunol. 2022;150:1114-1124.
    PubMed         Abstract available

  43. AKENROYE A, Lassiter G, Jackson JW, Keet C, et al
    Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis.
    J Allergy Clin Immunol. 2022 Jun 27. pii: S0091-6749(22)00846.
    PubMed         Abstract available

  44. CARDET JC, Shenoy K, Baydur A, Carroll JK, et al
    Caribbean Latinx with moderate-severe asthma bear greater asthma morbidity than other Latinx.
    J Allergy Clin Immunol. 2022 Jun 29. pii: S0091-6749(22)00885.
    PubMed         Abstract available

  45. CHEN Q, Dent AL
    Regulation of the IgE response by T follicular regulatory cells.
    J Allergy Clin Immunol. 2022;150:1048-1049.
    PubMed        

  46. PERSSON C
    Epithelial regeneration in vivo in pathogenesis of severe asthma.
    J Allergy Clin Immunol. 2022 Aug 29. pii: S0091-6749(22)01045.
    PubMed        

  47. WILLIAMS LK
    The time to PREPARE is over; the time to improve diversity in asthma studies is now.
    J Allergy Clin Immunol. 2022 Sep 22. pii: S0091-6749(22)01222.
    PubMed        


    J Immunol

  48. HONG L, Herjan T, Bulek K, Xiao J, et al
    Mechanisms of Corticosteroid Resistance in Type 17 Asthma.
    J Immunol. 2022 Sep 30. pii: jimmunol.2200288. doi: 10.4049/jimmunol.2200288.
    PubMed         Abstract available

  49. LAJINESS JD, Amarsaikhan N, Tat K, Tsoggerel A, et al
    beta-Glucosylceramides and Tocopherols Regulate Development and Function of Dendritic Cells.
    J Immunol. 2022;209:1837-1850.
    PubMed         Abstract available


    Pediatr Dermatol

  50. RICCIARDO BM, Kessaris HL, Kumarasinghe P, Carapetis JR, et al
    The burden of atopic dermatitis and bacterial skin infections among urban-living Indigenous children and young people in high-income countries: A systematic review.
    Pediatr Dermatol. 2022 Nov 9. doi: 10.1111/pde.15153.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: